Greg Duncan

Greg Duncan is the President and Chief Executive Officer of Celtaxsys, Inc. He was most recently Executive Vice President and President of North American Operations for Brussels based specialty pharma UCB. He was responsible for providing leadership and strategic direction to all aspects of the organization’s operations in North America. Prior to that, he was the President of European and Emerging Market Operations. Before joining UCB, Greg spent 17 years with Pfizer where he held several U.S. and international executive appointments, including SVP of Marketing and President of Pfizer’s Latin America Operations. His brand and general management teams had accountability for the launches of many “blockbuster” pharmaceutical brands including Lipitor, Zoloft, Viagra, Celebrex, Aricept, Lyrica, Cimzia, Zithromax (ZPack), Diflucan, Sutent and Vimpat.

Greg presently serves as an independent board director for Alliance Health and has served as a Board Director of the American Psychiatric Foundation, Biotie Therapeutics, Bio International Organization (BIO) and the Georgia Bio industry association groups. Greg holds a master’s degree in business administration from Emory University in Atlanta, GA, and a bachelor’s degree in economics from the State University of New York in Albany, NY. He and his wife Jennifer are the proud parents of three wonderful children.